TACSTD2 and Familial prostate cancer: In a recent study, Bedoya et al. (2019) have shown that TROP2-specific CAR T cells can target TROP2 expressing breast, pancreas and prostate cancer cells highlighting the potential of this TA to mediate the targeting of different types of solid cancer.